64 related articles for article (PubMed ID: 10206124)
1. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood.
Verhoef S; van Diemen-Steenvoorde R; Akkersdijk WL; Bax NM; Ariyurek Y; Hermans CJ; van Nieuwenhuizen O; Nikkels PG; Lindhout D; Halley DJ; Lips K; van den Ouweland AM
Eur J Pediatr; 1999 Apr; 158(4):284-7. PubMed ID: 10206124
[TBL] [Abstract][Full Text] [Related]
2. Annular eruption with weight loss in a 47-year-old man.
Annabi E; Lalevée S; Bettuzzi T; Demortier J; Papouin B; De Mestier Du Bourg L; Sbidian E; Ingen-Housz-Oro S
Frontline Gastroenterol; 2024 Mar; 15(2):177-178. PubMed ID: 38486674
[No Abstract] [Full Text] [Related]
3. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis.
Francalanci P; Diomedi-Camassei F; Purificato C; Santorelli FM; Giannotti A; Dominici C; Inserra A; Boldrini R
Am J Surg Pathol; 2003 Oct; 27(10):1386-9. PubMed ID: 14508401
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.
Arva NC; Pappas JG; Bhatla T; Raetz EA; Macari M; Ginsburg HB; Hajdu CH
Am J Surg Pathol; 2012 Jan; 36(1):149-53. PubMed ID: 22173120
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.
Larson AM; Hedgire SS; Deshpande V; Stemmer-Rachamimov AO; Harisinghani MG; Ferrone CR; Shah U; Thiele EA
Clin Genet; 2012 Dec; 82(6):558-63. PubMed ID: 22035404
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?
Arya S; Ventin M; Nebbia M; Fernandez-Del Castillo C; Lionetto G; Qadan M; Lillemoe KD; Deshpande V; Catalano OA; Thiele EA; Ferrone CR
Ann Surg Oncol; 2023 Nov; 30(12):7748-7755. PubMed ID: 37648887
[TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract][Full Text] [Related]
8. Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer.
Liu J; Mroczek M; Mach A; Stępień M; Aplas A; Pronobis-Szczylik B; Bukowski S; Mielczarek M; Gajewska E; Topolski P; Król ZJ; Szyda J; Dobosz P
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765737
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.
Maharjan CK; Ear PH; Tran CG; Howe JR; Chandrasekharan C; Quelle DE
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680266
[TBL] [Abstract][Full Text] [Related]
10. Genetic Drivers of Ileal Neuroendocrine Tumors.
Carpizo DR; Harris CR
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680217
[TBL] [Abstract][Full Text] [Related]
11. Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports.
Mowrey K; Northrup H; Rougeau P; Hashmi SS; Krueger DA; Ebrahimi-Fakhari D; Towbin AJ; Trout AT; Capal JK; Franz DN; Rodriguez-Buritica D
Front Neurol; 2021; 12():627672. PubMed ID: 33897589
[No Abstract] [Full Text] [Related]
12. Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system: a case report and review of the literature.
Reis LB; Konzen D; Netto CBO; Braghini PMB; Prolla G; Ashton-Prolla P
BMC Gastroenterol; 2020 Nov; 20(1):394. PubMed ID: 33225890
[TBL] [Abstract][Full Text] [Related]
13. Medical Management of Gastroenteropancreatic Neuroendocrine Tumors.
Chandrasekharan C
Surg Oncol Clin N Am; 2020 Apr; 29(2):293-316. PubMed ID: 32151362
[TBL] [Abstract][Full Text] [Related]
14. The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
Lamberti G; Brighi N; Maggio I; Manuzzi L; Peterle C; Ambrosini V; Ricci C; Casadei R; Campana D
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29509701
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic tumors in children and young adults with tuberous sclerosis complex.
Koc G; Sugimoto S; Kuperman R; Kammen BF; Karakas SP
Pediatr Radiol; 2017 Jan; 47(1):39-45. PubMed ID: 27639993
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.
Pyo JH; Hong SN; Min BH; Lee JH; Chang DK; Rhee PL; Kim JJ; Choi SK; Jung SH; Son HJ; Kim YH
J Gastroenterol; 2016 Dec; 51(12):1112-1121. PubMed ID: 27025841
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of pancreatic neuroendocrine tumors.
Ehehalt F; Franke E; Pilarsky C; Grützmann R
Cancers (Basel); 2010 Nov; 2(4):1901-10. PubMed ID: 24281208
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians.
Sharma J; Duque M; Saif MW
Therap Adv Gastroenterol; 2013 Nov; 6(6):474-90. PubMed ID: 24179483
[TBL] [Abstract][Full Text] [Related]
19. Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011.
Vickers MM; Pasieka J; Dixon E; McEwan S; McKay A; Renouf D; Schellenberg D; Ruether D
Curr Oncol; 2012 Dec; 19(6):e468-77. PubMed ID: 23300370
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumors.
Shrikhande SV; Sirohi B; Goel M; Barreto SG
Indian J Gastroenterol; 2013 Jan; 32(1):3-17. PubMed ID: 23054950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
